RCT for Pregabalin in Restless Legs Syndrome in South Korea
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled, multicenter clinical trial is designed to
to assess the treatment efficacy and tolerability of pregabalin in patients with idiopathic
restless legs syndrome in South Korea.